290 related articles for article (PubMed ID: 20678804)
21. Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel).
Venkatesh R; Agrawal S; Reddy NG; Mishra P; Mutalik D; Yadav NK; Chhablani J
Eye (Lond); 2023 Apr; 37(6):1061-1066. PubMed ID: 35422496
[TBL] [Abstract][Full Text] [Related]
22. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
[TBL] [Abstract][Full Text] [Related]
23. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
Spaide RF; Klancnik JM; Cooney MJ
JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).
Wu L; Evans T; Arevalo JF
Surv Ophthalmol; 2013; 58(6):536-59. PubMed ID: 24160729
[TBL] [Abstract][Full Text] [Related]
25. Different types of macular telangiectasia in two eyes of a patient.
Venkatesh R; Reddy NG; Pereira A; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Sep; 32(5):NP9-NP12. PubMed ID: 33960244
[TBL] [Abstract][Full Text] [Related]
26. Volume-Rendering Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.
Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Balaratnasingam C; Dansingani KK; Suzuki M
Ophthalmology; 2015 Nov; 122(11):2261-9. PubMed ID: 26315043
[TBL] [Abstract][Full Text] [Related]
27. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
[TBL] [Abstract][Full Text] [Related]
28. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
29. Demographic features of idiopathic macular telangiectasia in Japanese patients.
Maruko I; Iida T; Sugano Y; Ojima A; Oyamada H; Sekiryu T
Jpn J Ophthalmol; 2012 Mar; 56(2):152-8. PubMed ID: 22219035
[TBL] [Abstract][Full Text] [Related]
30. Drusen-associated degeneration in the retina.
Johnson PT; Lewis GP; Talaga KC; Brown MN; Kappel PJ; Fisher SK; Anderson DH; Johnson LV
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4481-8. PubMed ID: 14507896
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic preretinal glia in aging and age-related macular degeneration.
Edwards MM; McLeod DS; Bhutto IA; Villalonga MB; Seddon JM; Lutty GA
Exp Eye Res; 2016 Sep; 150():44-61. PubMed ID: 26220834
[TBL] [Abstract][Full Text] [Related]
32. Relationship between macular microcirculation and progression of diabetic macular edema.
Sakata K; Funatsu H; Harino S; Noma H; Hori S
Ophthalmology; 2006 Aug; 113(8):1385-91. PubMed ID: 16877077
[TBL] [Abstract][Full Text] [Related]
33. Photoreceptor and glial markers in human embryonic retina and in human embryonic retinal transplants to rat retina.
Seiler MJ; Aramant RB
Brain Res Dev Brain Res; 1994 Jul; 80(1-2):81-95. PubMed ID: 7955364
[TBL] [Abstract][Full Text] [Related]
34. Macular telangiectasia--changes in macular pigment optical density during a 5-year follow-up.
Zeimer MB; Spital G; Heimes B; Lommatzsch A; Pauleikhoff D
Retina; 2014 May; 34(5):920-8. PubMed ID: 24150241
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia.
Cherepanoff S; Killingsworth MC; Zhu M; Nolan T; Hunyor AP; Young SH; Hageman GS; Gillies MC
Br J Ophthalmol; 2012 Nov; 96(11):1404-9. PubMed ID: 22976584
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy.
Bek T
Acta Ophthalmol Scand; 1997 Aug; 75(4):388-92. PubMed ID: 9374245
[TBL] [Abstract][Full Text] [Related]
37. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
[TBL] [Abstract][Full Text] [Related]
38. CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
Matet A; Yzer S; Chew EY; Daruich A; Behar-Cohen F; Spaide RF
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S67-S78. PubMed ID: 29016451
[TBL] [Abstract][Full Text] [Related]
39. The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2.
Zhu M; Krilis M; Gillies MC
Retina; 2013 Sep; 33(8):1547-50. PubMed ID: 23974952
[TBL] [Abstract][Full Text] [Related]
40. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
Lee S; Kim HA; Yoon YH
Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
